Switch theme
Sign up to access all valuation multiples
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2023, the platform has over 180 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com
2018
3.2K+
LTM Revenue $8.9B
LTM EBITDA $445M
$8.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
JD Health has a last 12-month revenue of $8.9B and a last 12-month EBITDA of $445M.
In the most recent fiscal year, JD Health achieved revenue of $6.9B and an EBITDA of $377M.
JD Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See JD Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $6.0B | $6.9B | XXX | XXX | XXX |
| Gross Profit | $926M | $1.3B | XXX | XXX | XXX |
| Gross Margin | 15% | 18% | XXX | XXX | XXX |
| EBITDA | $109M | $377M | XXX | XXX | XXX |
| EBITDA Margin | 2% | 5% | XXX | XXX | XXX |
| Net Profit | -$138M | $48.9M | XXX | XXX | XXX |
| Net Margin | -2% | 1% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, JD Health's stock price is HKD 36 (or $5).
JD Health has current market cap of HKD 114B (or $14.7B), and EV of HKD 63.4B (or $8.2B).
See JD Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.2B | $14.7B | XXX | XXX | XXX | XXX | $0.17 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, JD Health has market cap of $14.7B and EV of $8.2B.
JD Health's trades at 1.0x LTM EV/Revenue multiple, and 19.6x LTM EBITDA.
Analysts estimate JD Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for JD Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $8.2B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 21.6x | XXX | XXX | XXX |
| P/E | 53.4x | XXX | XXX | XXX |
| P/E/Growth | 1.3x | XXX | XXX | XXX |
| EV/FCF | 14.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpJD Health's NTM/LTM revenue growth is 12%
JD Health's revenue per employee for the last fiscal year averaged $2.2M, while opex per employee averaged $0.5M for the same period.
Over next 12 months, JD Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate JD Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for JD Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 247% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 18% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $2.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 21% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JD Health acquired XXX companies to date.
Last acquisition by JD Health was XXXXXXXX, XXXXX XXXXX XXXXXX . JD Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was JD Health founded? | JD Health was founded in 2018. |
| Where is JD Health headquartered? | JD Health is headquartered in Hong Kong. |
| How many employees does JD Health have? | As of today, JD Health has 3.2K+ employees. |
| Who is the CEO of JD Health? | JD Health's CEO is Mr. Enlin Jin. |
| Is JD Health publicy listed? | Yes, JD Health is a public company listed on HKG. |
| What is the stock symbol of JD Health? | JD Health trades under 06618 ticker. |
| When did JD Health go public? | JD Health went public in 2020. |
| Who are competitors of JD Health? | Similar companies to JD Health include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of JD Health? | JD Health's current market cap is $14.7B |
| What is the current revenue of JD Health? | JD Health's last 12-month revenue is $8.9B. |
| What is the current EBITDA of JD Health? | JD Health's last 12-month EBITDA is $445M. |
| What is the current EV/Revenue multiple of JD Health? | Current revenue multiple of JD Health is 1.0x. |
| What is the current EV/EBITDA multiple of JD Health? | Current EBITDA multiple of JD Health is 19.6x. |
| What is the current revenue growth of JD Health? | JD Health revenue growth between 2023 and 2024 was 15%. |
| Is JD Health profitable? | Yes, JD Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
